日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies

在药物发现研究的临床前和临床阶段,应用质量源于设计(QbD)方法开发色谱分析方法,以测定物质的完整杂质谱。

Gurba-Bryśkiewicz, Lidia; Dawid, Urszula; Smuga, Damian A; Maruszak, Wioleta; Delis, Monika; Szymczak, Krzysztof; Stypik, Bartosz; Moroz, Aleksandra; Błocka, Aleksandra; Mroczkiewicz, Michał; Dubiel, Krzysztof; Wieczorek, Maciej

Studies of the synthesis of all stereoisomers of MG-132 proteasome inhibitors in the tumor targeting approach

MG-132蛋白酶体抑制剂在肿瘤靶向药物合成中的全立体异构体研究

Michał Mroczkiewicz, Katarzyna Winkler, Dominika Nowis, Grzegorz Placha, Jakub Golab, Ryszard Ostaszewski